Neurovascular Devices/Interventional Neurology Market by Product and by Pathology - Global Forecasts to 2021

  • ID: 4088786
  • Report
  • Region: Global
  • 195 Pages
  • Markets and Markets
1 of 5
Neurovascular Devices/Interventional Neurology Market worth 2.62 Billion USD by 2021

FEATURED COMPANIES

  • Abbott Laboratories
  • Johnson & Johnson
  • Medtronic PLC
  • Penumbra, Inc.
  • Stryker Corporation
  • Terumo Corporation
  • MORE

"Neurovascular Devices/Interventional Neurology Market by Product (Embolic Coils, Stents, Neurothrombectomy Devices, Microcatheters, Balloon Occlusion Devices, Flow Diversion Devices, Clot Retrievers), Pathology (Aneurysm, AVM) - Global Forecasts to 2021"

The global neurovascular devices/interventional neurology market is estimated reach USD 2.62 million at a CAGR of 8.6% during 2016-2021. As of 2016, North America and Europe holds the largest share of the market; however, the Asia-Pacific region is poised to be the fastest growing region during next five years owing to factors such as the presence of a large patient population base for target diseases, rising awareness among neurosurgeons related to the benefits offered by interventional neurology devices, ongoing government initiatives to modernize & expand healthcare infrastructure, and increasing adoption of neurovascular devices due to decreasing product price (owing to increasingly localized manufacturing and strengthening of distribution networks).

Market growth in the market is mainly driven by factors such as large target patient population base, ongoing product development & commercialization, favorable medical reimbursements, expansion of healthcare infrastructure across emerging markets and growing market demand for effective neurovascular devices. The factors such as the increasing number of research activities in the field of neurovascular therapies and rising demand for minimally invasive neurosurgical procedures are expected to offer renewed growth opportunities for the market players during the forecast period.

Geographically, North America is estimated to command the largest share of the global market in 2016, followed by Europe. The large market share of the North American region can be attributed to increasing adoption of neurovascular devices among neurosurgeons in neurovascular disease treatment, the growing number of clinical trials (that aim to evaluate the therapeutic efficacy of neurovascular devices in specific disease treatment), significant medical reimbursement available in the U.S. for neurosurgical procedures, large patient population for target diseases, favorable reimbursement scenario, strong presence of device manufacturers in the region, and availability of significant R&D investments to support neurovascular product development. However, market growth will be negatively affected due to the unfavorable regulatory scenario in the region, which may result in increased pricing pressure on key neurovascular device manufacturers.

The market is highly competitive, with a large number of global and local manufacturers of neurovascular products. Stryker Corporation (U.S.), Medtronic Plc (Ireland), and Johnson & Johnson (U.S.) were the top three players in the market, in 2015.

Report Objective:

This report studies neurovascular devices/interventional neurology market based on products, disease pathology, and region.

The report also studies, the factors (such as drivers, restraints, opportunities, and challenges) which affect the market growth in a positive and negative manner. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. Furthermore, the neurovascular devices/interventional neurology market report analyzes the micromarkets with respect to their individual growth trends, prospects, and contributions to the neurovascular devices/interventional neurology market.

Reasons to buy the report:

From an insights perspective, this research report is focused on various levels of analysis-industry trends, market share analysis of top ten players, and company profiles, which together discuss basic views on the competitive landscape, emerging and high growth segments of the neurovascular devices/interventional neurology market, and high growth regions and their respective drivers, restraints, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering greater market shares. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on product portfolios offered by the major players in the neurovascular devices/interventional neurology market. The report analyzes the market based on product, disease pathology, and region.
  • Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and product launches in the neurovascular devices/interventional neurology market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various neurovascular devices/interventional neurology products across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the neurovascular devices/interventional neurology market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the neurovascular devices/interventional neurology market
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Johnson & Johnson
  • Medtronic PLC
  • Penumbra, Inc.
  • Stryker Corporation
  • Terumo Corporation
  • MORE

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Breakdown of Primaries
2.2 Opportunity Indicators
2.2.1 Target Disease Prevalence
2.2.2 Rising Geriatric Population
2.2.3 Number of Hospitals and Surgical Centers
2.2.4 Healthcare Expenditure
2.2.5 Increasing Clinical Research
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Market Breakdown and Data Triangulation
2.5 Research Assumptions
2.5.1 Assumptions

3 Executive Summary

4 Premium Insights
4.1 Neurovascular Devices/Interventional Neurology Market Overview
4.2 Global Neurovascular Devices/Interventional Neurology Product Market, By Region (2016 vs 2021)
4.3 Global Neurovascular Devices/Interventional Neurology Market, By Product (2016 vs 2021)
4.4 Global Neurovascular Devices/Interventional Neurology Market for Disease Pathology, By Region (2016-2021)
4.5 Neurovascular Devices/Interventional Neurology Market, By Country (2016 vs 2021)

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Key Market Drivers
5.2.1.1 Large Target Patient Population
5.2.1.2 Ongoing Product Development and Commercialization
5.2.1.3 Favorable Medical Reimbursements
5.2.1.4 Expansion of Healthcare Infrastructure Across Emerging Markets
5.2.1.5 Growing Market Demand for Effective Neurovascular Devices
5.2.2 Key Market Restraints
5.2.2.1 Stringent Regulations
5.2.2.2 Dearth of Skilled Neurosurgeons
5.2.3 Key Market Opportunities
5.2.3.1 Increasing Research Activities in the Field of Neurovascular Therapies
5.2.3.2 Rising Demand for Minimally Invasive Neurosurgical Procedures
5.3 Ongoing Clinical Studies
5.3.1 Embolization Coiling Procedures
5.3.2 Carotid Artery Stenting Procedures
5.3.3 Embolic Protection Procedures
5.3.4 Flow Diversion Procedures
5.3.5 Supporting Techniques
5.3.6 Neurothrombectomy Procedures

6 Industry Insights
6.1 Introduction
6.2 Supply Chain Analysis
6.3 Porter’s Five Forces Analysis
6.4 Industry Trends
6.4.1 Increasing Awareness Among Surgeons About Benefits of Stereotactic Framework Procedures in Neurosurgeries
6.4.2 Channel Optimization

7 Neurovascular Devices/Interventional Neurology Market, By Product
7.1 Introduction
7.2 Aneurysm Coiling & Embolization Devices
7.2.1 Embolic Coils
7.2.1.1 Bare Detachable Coils
7.2.1.2 Coated Detachable Coils
7.2.2 Flow Diversion Devices
7.2.3 Liquid Embolic Agents
7.3 Cerebral Balloon Angioplasty and Stenting Systems
7.3.1 Carotid Artery Stents
7.3.2 Embolic Protection Systems
7.3.2.1 Distal Filter Devices
7.3.2.2 Balloon Occlusion Devices
7.4 Support Devices
7.4.1 Microcatheters
7.4.2 Microguidewires
7.5 Neurothrombectomy Devices
7.5.1 Clot Retrieval Devices
7.5.2 Suction and Aspiration Devices
7.5.3 Snares

8 Global Neurovascular Devices/Interventional Neurology Market, By Disease Pathology
8.1 Introduction
8.2 Ischemic Strokes
8.3 Cerebral Aneurysms
8.4 Arteriovenous Malformation and Fistulas
8.5 Other Disease Pathologies

9 Global Neurovascular Devices/Interventional Neurology Market, By Region
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 U.K.
9.3.4 Rest of Europe
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Rest of Asia-Pacific
9.5 Rest of the World (RoW)

10 Competitive Landscape
10.1 Overview
10.2 Market Share Analysis
10.3 Competitive Scenario
10.4 Recent Developments
10.4.1 Product Launches
10.4.2 Strategic Acquisitions
10.4.3 Expansions
10.4.4 Agreements and Collaborations
10.4.5 Other Developments

11 Company Profiles
(Business Overview, Products Offered, Key Insights, Recent Developments, MnM View)*
11.1 Introduction
11.1.1 Geographic Benchmarking
11.2 Stryker Corporation
11.3 Medtronic PLC
11.4 Johnson & Johnson
11.5 Terumo Corporation
11.6 Penumbra, Inc.
11.7 Boston Scientific Corporation
11.8 Microport Scientific Corporation
11.9 Merit Medical Systems, Inc.
11.10 W.L. Gore & Associates, Inc.
11.11 Abbott Laboratories

*Details on Business Overview, Products Offered, Key Insights, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.

12 Appendix
12.1 Insights of Industry Experts
12.2 Discussion Guide
12.3 Knowledge Store
12.4 Introducing RT: Real-Time Market Intelligence
12.5 Available Customizations
12.6 Related Reports
12.7 Author Details

List of Tables:
Table 1 Embolization Coils: Ongoing Clinical Trials (As of December 2016)
Table 2 Carotid Stents: Ongoing Clinical Trials (As of December 2016)
Table 3 Distal Filter and Balloon Occlusion Catheters: Ongoing Clinical Trials (As of December 2016)
Table 4 Flow Diversion Devices: Ongoing Clinical Trials (As of December 2016)
Table 5 Microcatheters: Ongoing Clinical Trials (As of December 2016)
Table 6 Clot Retrieval, Suction, and Aspiration Devices: Ongoing Clinical Trials (As of December 2016)
Table 7 Global Neurovascular Devices/Interventional Neurology Market Size, By Product, 2014-2021 (USD Million)
Table 8 Global Neurovascular Devices/Interventional Neurology Market Size, By Region, 2014-2021 (USD Million)
Table 9 Global Neurovascular Devices/Interventional Neurology Market Size, By Product, 2014-2021 (Units)
Table 10 Global Aneurysm Coiling & Embolization Devices Market Size, By Type, 2014-2021 (USD Million)
Table 11 Global Aneurysm Coiling & Embolization Devices Market Size, By Type, 2014-2021 (Units)
Table 12 Global Aneurysm Coiling & Embolization Devices Market Size, By Region, 2014-2021 (USD Million)
Table 13 Embolic Coils: Global Aneurysm Coiling & Embolization Devices Market Size, By Type, 2014-2021 (USD Million)
Table 14 Embolic Coils: Global Aneurysm Coiling & Embolization Devices Market Size, By Type, 2014-2021 (Units)
Table 15 Embolic Coils: Aneurysm Coiling & Embolization Devices Market Size, By Region, 2014-2021 (USD Million)
Table 16 Bare Detachable Coils: Aneurysm Coiling & Embolization Devices Market Size, By Region, 2014-2021 (USD Million)
Table 17 Bare Detachable Coils: Aneurysm Coiling & Embolization Devices Market Size, By Region, 2014-2021 (Units)
Table 18 Coated Detachable Coils: Global Aneurysm Coiling & Embolization Devices Market Size, By Region, 2014-2021 (USD Million)
Table 19 Coated Detachable Coils: Global Aneurysm Coiling & Embolization Devices Market Size, By Region, 2014-2021 (Units)
Table 20 Flow Diversion Devices: Global Aneurysm Coiling & Embolization Devices Market Size, By Region, 2014-2021 (USD Million)
Table 21 Flow Diversion Devices: Global Aneurysm Coiling & Embolization Devices Market Size, By Region, 2014-2021 (Units)
Table 22 Liquid Embolic Agents: Global Aneurysm Coiling & Embolization Devices Market Size, By Region, 2014-2021 (USD Million)
Table 23 Liquid Embolic Agents: Global Aneurysm Coiling & Embolization Devices Market Size, By Region, 2014-2021 (Units)
Table 24 Cerebral Balloon Angioplasty and Stenting Systems Market Size, By Type, 2014-2021 (USD Million)
Table 25 Cerebral Balloon Angioplasty and Stenting Systems Market Size, By Type, 2014-2021 (Units)
Table 26 Global Cerebral Balloon Angioplasty and Stenting Systems Market Size, By Region, 2014-2021 (USD Million)
Table 27 Carotid Artery Stents: Global Cerebral Balloon Angioplasty and Stenting Systems Market Size, By Region, 2014-2021 (USD Million)
Table 28 Carotid Artery Stents: Global Cerebral Balloon Angioplasty and Stenting Systems Market Size, By Region, 2014-2021 (Units)
Table 29 Embolic Protection Systems: Cerebral Balloon Angioplasty and Stenting Systems Market Size, By Type, 2014-2021 (USD Million)
Table 30 Embolic Protection Systems: Cerebral Balloon Angioplasty and Stenting Systems Market Size, By Type, 2014-2021 (Units)
Table 31 Embolic Protection Systems: Cerebral Balloon Angioplasty and Stenting Systems Market Size, By Region, 2014-2021 (USD Million)
Table 32 Distal Filter Devices: Cerebral Balloon Angioplasty and Stenting Systems Market Size, By Region, 2014-2021 (USD Million)
Table 33 Distal Filter Devices: Cerebral Balloon Angioplasty and Stenting Systems Market Size, By Region, 2014-2021 (Units)
Table 34 Balloon Occlusion Devices: Embolic Protection Systems Market Size, By Region, 2014-2021 (USD Million)
Table 35 Balloon Occlusion Devices: Embolic Protection Systems Market Size, By Region, 2014-2021 (Units)
Table 36 Support Devices: Neurovascular Devices/Interventional Neurology Market Size, By Type, 2014-2021 (USD Million)
Table 37 Support Devices: Global Neurovascular Devices/Interventional Neurology Market Size, By Type, 2014-2021 (Units)
Table 38 Support Devices: Neurovascular Devices/Interventional Neurology Market Size, By Region, 2014-2021 (USD Million)
Table 39 Microcatheters: Neurovascular Support Devices Market Size, By Region, 2014-2021 (USD Million)
Table 40 Microcatheters: Neurovascular Support Devices Market Size, By Region, 2014-2021 (Units)
Table 41 Microguidewires: Neurovascular Support Devices Market Size, By Region, 2014-2021 (USD Million)
Table 42 Microguidewires: Neurovascular Support Devices Market Size, By Region, 2014-2021 (Units)
Table 43 Global Neurothrombectomy Devices Market Size, By Type, 2014-2021 (USD Million)
Table 44 Global Neurothrombectomy Devices Market Size, By Type, 2014-2021 (Units)
Table 45 Global Neurothrombectomy Devices Market Size, By Region, 2014-2021 (USD Million)
Table 46 Clot Retrievers: Global Neurothrombectomy Devices Market Size, By Region, 2014-2021 (USD Million)
Table 47 Clot Retrievers: Global Neurothrombectomy Devices Market Size, By Region, 2014-2021 (Units)
Table 48 Suction & Aspiration Devices: Global Neurothrombectomy Devices Market Size, By Region, 2014-2021 (USD Million)
Table 49 Suction & Aspiration Devices: Global Neurothrombectomy Devices Market Size, By Region, 2014-2021 (Units)
Table 50 Snares: Global Neurothrombectomy Devices Market Size, By Region, 2014-2021 (USD Million)
Table 51 Snares: Global Neurothrombectomy Devices Market Size, By Region, 2014-2021 (Units)
Table 52 Disease Pathology: Global Neurovascular Devices/Interventional Neurology Market Size, 2014-2021 (USD Million)
Table 53 Disease Pathology: Global Neurovascular Devices/Interventional Neurology Market Size, By Region, 2014-2021 (USD Million)
Table 54 Ischemic Strokes Pathology: Global Neurovascular Devices/Interventional Neurology Market Size, By Region, 2014-2021 (USD Million)
Table 55 Cerebral Aneurysms Pathology: Global Neurovascular Devices/Interventional Neurology Market Size, By Region, 2014-2021 (USD Million)
Table 56 Arteriovenous Malformation and Fistulas Pathology: Global Neurovascular Devices/Interventional Neurology Market Size, By Region, 2014-2021 (USD Million)
Table 57 Other Disease Pathologies: Global Neurovascular Devices/Interventional Neurology Market Size, By Region, 2014-2021 (USD Million)
Table 58 Global Neurovascular Devices/Interventional Neurology Market Size, By Region, 2014-2021 (USD Million)
Table 59 North America: Neurovascular Devices/Interventional Neurology Market Size, By Country, 2014-2021 (USD Million)
Table 60 North America: Neurovascular Devices/Interventional Neurology Market Size, By Product, 2014-2021 (USD Million)
Table 61 North America: Aneurysm Coiling and Embolization Devices Market Size, By Product , 2014-2021 (USD Million)
Table 62 North America: Cerebral Balloon Angioplasty and Stenting Systems Market Size, By Product, 2014-2021 (USD Million)
Table 63 North America: Support Devices Market Size, By Product, 2014-2021 (USD Million)
Table 64 North America: Neurothrombectomy Devices Market Size, By Product, 2014-2021 (USD Million)
Table 65 North America: Neurovascular Devices/Interventional Neurology Market Size, By Disease Pathology, 2014-2021 (USD Million)
Table 66 U.S.: Neurovascular Devices/Interventional Neurology Market Size, By Product, 2014-2021 (USD Million)
Table 67 Canada: Neurovascular Devices/Interventional Neurology Market Size, By Product, 2014-2021 (USD Million)
Table 68 Europe: Neurovascular Devices/Interventional Neurology Market Size, By Country, 2014-2021 (USD Million)
Table 69 Europe: Neurovascular Devices/Interventional Neurology Market Size, By Product, 2014-2021 (USD Million)
Table 70 Europe: Aneurysm Coiling and Embolization Devices Market Size, By Product, 2014-2021 (USD Million)
Table 71 Europe: Cerebral Balloon Angioplasty and Stenting Systems Market Size, By Product , 2014-2021 (USD Million)
Table 72 Europe: Support Devices Market Size, By Product , 2014-2021 (USD Million)
Table 73 Europe: Neurothrombectomy Devices Market Size, By Product, 2014-2021 (USD Million)
Table 74 Europe: Neurovascular Devices/Interventional Neurology Market Size, By Disease Pathology, 2014-2021 (USD Million)
Table 75 Germany: Neurovascular Devices/Interventional Neurology Market Size, By Product, 2014-2021 (USD Million)
Table 76 France: Neurovascular Devices/Interventional Neurology Market Size, By Product, 2014-2021 (USD Million)
Table 77 U.K.: Neurovascular Devices/Interventional Neurology Market Size, By Product, 2014-2021 (USD Million)
Table 78 RoE: Neurovascular Devices/Interventional Neurology Market Size, By Product, 2014-2021 (USD Million)
Table 79 Asia-Pacific: Neurovascular Devices/Interventional Neurology Market Size, By Country, 2014-2021 (USD Million)
Table 80 Asia-Pacific: Neurovascular Devices/Interventional Neurology Market Size, By Product, 2014-2021 (USD Million)
Table 81 Asia-Pacific: Aneurysm Coiling and Embolization Devices Market Size, By Product, 2014-2021 (USD Million)
Table 82 Asia-Pacific: Cerebral Balloon Angioplasty and Stenting Systems Market Size, By Product, 2014-2021 (USD Million)
Table 83 Asia-Pacific: Support Devices Market Size, By Product, 2014-2021 (USD Million)
Table 84 Asia-Pacific: Neurothrombectomy Devices Market Size, By Product, 2014-2021 (USD Million)
Table 85 Asia-Pacific: Neurovascular Devices/Interventional Neurology Market Size, By Disease Pathology, 2014-2021 (USD Million)
Table 86 Japan: Neurovascular Devices/Interventional Neurology Market Size, By Product, 2014-2021 (USD Million)
Table 87 China: Neurovascular Devices/Interventional Neurology Market Size, By Product, 2014-2021 (USD Million)
Table 88 India: Neurovascular Devices/Interventional Neurology Market Size, By Product, 2014-2021 (USD Million)
Table 89 RoAPAC: Neurovascular Devices/Interventional Neurology Market Size, By Product, 2014-2021 (USD Million)
Table 90 RoW: Neurovascular Devices/Interventional Neurology Market Size, By Product, 2014-2021 (USD Million)
Table 91 RoW: Aneurysm Coiling and Embolization Devices Market Size, By Product, 2014-2021 (USD Million)
Table 92 RoW: Cerebral Balloon Angioplasty and Stenting Systems Market Size, By Product, 2014-2021 (USD Million)
Table 93 RoW: Support Devices Market Size, By Product, 2014-2021 (USD Million)
Table 94 RoW: Neurothrombectomy Devices Market Size, By Product, 2014-2021 (USD Million)
Table 95 RoW: Neurovascular Devices/Interventional Neurology Market Size, By Disease Pathology, 2014-2021 (USD Million)
Table 96 Top Product Launches (2013-2016)
Table 97 Top Strategic Acquisitions (2013-2016)
Table 98 Top Expansions (2013-2016)
Table 99 Top Agreements and Collaborations (2013-2016)
Table 100 Other Developments (2013-2016)

List of Figures:
Figure 1 Global Neurovascular Devices/Interventional Neurology Market Segmentation
Figure 2 Research Design
Figure 3 Global Stroke Prevalence, By Country, 2015
Figure 4 Increase in Global Geriatric Population, By Country (2010-2015)
Figure 5 Increase in Proportion of Geriatric Individuals in Overall World Population, By Country (2011-2030)
Figure 6 Percentage Increase in Geriatric Population in Total World Population, By Region (1980-2010 vs 2010-2040)
Figure 7 Global Healthcare Expenditure, By Country (2000 vs 2014)
Figure 8 Global Healthcare Expenditure, By Region (2000 vs 2014)
Figure 9 Global Healthcare Spending Matrix, By Key Market (2014)
Figure 10 Bottom-Up Approach
Figure 11 Top-Down Approach
Figure 12 Data Triangulation
Figure 13 Assumptions of the Research Study
Figure 14 Global Neurovascular Devices/Interventional Neurology Market, By Product (2016 vs 2021)
Figure 15 Global Neurovascular Devices/Interventional Neurology Market, By Pathology (2016 vs 2021)
Figure 16 Global Neurovascular Devices/Interventional Neurology Market, By Region (2016 vs 2021)
Figure 17 North America to Dominate Global Neurovascular Devices/Interventional Neurology Market During 2016-2021
Figure 18 Growing Target Patient Population to Drive Market Demand for Interventional Neurology Products During 2016-2021
Figure 19 Aneurysm Coiling & Embolization Devices to Dominate Neurovascular Devices/Interventional Neurology Market, By Product, Until 2021
Figure 20 Embolic Coils to Contribute the Highest to Interventional Neurology Market, By Product, During 2016-2021 (USD Million)
Figure 21 Ischemic Stroke Segment to Lead Global Neurovascular Devices/Interventional Neurology Market, By Pathology, During 2016-2021
Figure 22 China and India to Be the Fastest Growing Countries in Global Interventional Neurology Market During 2016-2021
Figure 23 Neurovascular Devices/Interventional Neurology Market: Drivers, Restraints, Opportunities, and Challenges
Figure 24 Proportion of Geriatric Population to Total World Population, By Country, (2012 vs 2020)
Figure 25 Global Trend in Government Healthcare Expenditure: Developed vs Developing Countries (2010 vs 2014)
Figure 26 Ongoing Clinical Trials in Global Neurovascular Devices/Interventional Neurology Market (As of December 2016)
Figure 27 Supply Chain Analysis: Neurovascular Devices/Interventional Neurology Market (As of 2016)
Figure 28 Porter’s Five Forces Analysis (2016): Growing Adoption of Neurovascular Products Translating Into Higher Market Demand
Figure 29 Cerebral Balloon Angioplasty & Stenting Systems to Record Highest Growth During 2016-2021 (USD Million)
Figure 30 Embolic Coils Segment to Lead Aneurysm Coiling and Embolization Devices Market During 2016-2021 (USD Million)
Figure 31 Carotid Artery Stents Segment to Record Highest Growth in Cerebral Balloon Angioplasty & Stenting Systems Market Until 2021 (USD Million)
Figure 32 Microcatheters to Hold Largest Share of Support Devices Segment During 2016-2021 (USD Million)
Figure 33 Clot Retrievers to Record Highest Growth in Neurothrombectomy Devices Market, By Type, During 2016-2021 (USD Million)
Figure 34 Ischemic Stroke to Record Fastest Growth in Neurovascular Devices/Interventional Neurology Market, By Disease Pathology, During 2016-2021 (USD Million)
Figure 35 North America to Dominate Global Neurovascular Devices/Interventional Neurology Market for Ischemic Strokes Till 2021 (USD Million)
Figure 36 North America: Neurovascular Devices/Interventional Neurology Market Snapshot
Figure 37 Europe: Neurovascular Devices/Interventional Neurology Market Snapshot
Figure 38 Asia-Pacific: Neurovascular Devices/Interventional Neurology Market Snapshot
Figure 39 RoW: Neurovascular Devices/Interventional Neurology Market Snapshot
Figure 40 Product Launches & Commercialization the Key Growth Strategy Adopted By Majority of Market Players Between 2013 and 2016
Figure 41 Global Neurovascular Devices/Interventional Neurology Market Share, By Key Players (2015)
Figure 42 Growing Number of Product Launches and Enhancements Driving Market Growth
Figure 43 Geographic Revenue Mix of Top Four Players in Global Neurovascular Devices/Interventional Neurology Market
Figure 44 Stryker Corporation: Company Snapshot (2015)
Figure 45 Medtronic PLC: Company Snapshot (2015)
Figure 46 Johnson & Johnson: Company Snapshot (2015)
Figure 47 Terumo Corporation: Company Snapshot (2015)
Figure 48 Penumbra, Inc.: Company Snapshot (2015)
Figure 49 Boston Scientific Corporation: Company Snapshot (2015)
Figure 50 Microport Scientific Corporation: Company Snapshot (2015)
Figure 51 Merit Medical Systems, Inc.: Company Snapshot (2015)
Figure 52 Abbott Laboratories: Company Snapshot (2015)

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Johnson & Johnson
  • Medtronic PLC
  • Penumbra, Inc.
  • Stryker Corporation
  • Terumo Corporation
  • MORE

The global neurovascular devices/interventional neurology market is expected to reach a value of USD 2.62 Billion by 2021; growing at a CAGR of 8.6% during 2016-2021. A number of factors such as growing target patient population, ongoing product development & commercialization, favorable medical reimbursements, expansion of healthcare infrastructure across emerging markets, growing market demand for effective neurovascular devices, increasing number of researches in the field of neurovascular therapies, rising demand for minimally invasive neurosurgical procedures, and increasing awareness among neurosurgeons about minimally invasive surgical procedures. However, dearth of skilled neurosurgeons and stringent regulatory policies are the key challenges faced by leading players in the global neurovascular devices/interventional neurology market.

On the basis of products, the neurovascular devices/interventional neurology market is segmented into aneurysm coiling and embolization devices, cerebral balloon angioplasty and stenting systems, support devices, and neurothrombectomy devices. The aneurysm coiling and embolization devices segment is expected to hold the largest share of the interventional neurology market in 2016. The large market share of this segment can be attributed to the growing end-user preference for minimally invasive neurosurgical procedures and increasing market availability of embolic coils for neurovascular treatment.

On the basis of pathology, the neurovascular devices/interventional neurology market is segmented into ischemic strokes, cerebral aneurysm, arteriovenous malformations & fistulas, and other diseases. The ischemic strokes segment is expected to hold the largest share of the global neurovascular devices/interventional neurology market in 2016. Dominant market position of ischemic strokes segment is attributed to rising prevalence of ischemic stroke (coupled with exposure of larger proportion of global population to major risk factors such as smoking and diabetes), and increasing patient preference for minimally invasive therapeutic neurosurgical technologies.

On the basis of geography, this market is classified into four regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World. In 2016, the global interventional neurology market is expected to be dominated by North America. North American region is expected to dominate the neurovascular devices/interventional neurology market during study period owing to significant adoption of neurovascular devices among neurosurgeons in neurovascular disease treatment, growing number of clinical trials (that aim to evaluate the therapeutic efficacy of neurovascular devices) and significant medical reimbursement available in the U.S. for neurosurgical procedures.

New product launches and enhancements are the key growth strategies adopted by major players to develop their positions in the global neurovascular devices/interventional neurology market. Moreover, strategies such as agreements and collaborations; strategic acquisitions; and market expansions were also adopted by a significant number of market players to strengthen their product portfolios, distribution networks and expand their geographic presence in the global neurovascular devices/interventional neurology market.

As of 2015, Stryker Corporation (U.S.), Medtronic plc (U.S.), Johnson & Johnson (U.S.), and Terumo Corporation (Japan) are the top four players in the market. Other prominent players present in the market include Penumbra, Inc. (U.S.), Abbott Laboratories (U.S.), Merit Medical Systems, Inc. (U.S.), W. L. Gore & Associates, Inc. (U.S.), and MicroPort Scientific Corporation (China), among others.

Note: Product cover images may vary from those shown
5 of 5
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Johnson & Johnson
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Microport Scientific Corporation
  • Penumbra, Inc.
  • Stryker Corporation
  • Terumo Corporation
  • W.L. Gore & Associates, Inc.
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll